Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-10-14, the close was $91.97: 0.4% below the 50-day average and 6.7% above the 200-day average, which is rising. RSI (14) is 53, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 79% of the way up its 52-week range of $61.64 to $99.84, on 1.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $92.32 | Price 0.4% below |
| 200-day average | $86.17 | Price 6.7% above, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 53 | Neutral range |
| MACD (12, 26, 9) | -0.36 vs -0.93 | Bullish cross in the last 10 days |
| 52-week range | $61.64 to $99.84 | 79% of the way up the range |
| Volume vs 20-day average | 1.0x | Normal |
Base rates use OKE's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-14, OKE's 14-day RSI is 53, which is in the neutral range between 30 and 70.
Yes. OKE closed at $91.97 on 2026-10-14, 6.7% above its 200-day average of $86.17, which is rising. When it closed above its 200-day average (4,709 days), it was higher 63 trading days later 68% of the time, median +5.2%.
No. OKE closed at $91.97 on 2026-10-14, 0.4% below its 50-day average of $92.32. When it closed below its 50-day average (2,450 days), it was higher 63 trading days later 64% of the time, median +5.6%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-14 the MACD line is -0.36 against a signal line of -0.93, so MACD is bullish.
No. At $91.97 it sits 79% of the way up its 52-week range of $61.64 to $99.84, 7.9% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 1 bearish as of 2026-10-14 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
OKE analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.